Cargando…

A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein

Zika virus (ZIKV) infection poses a serious threat to human health. However, no licensed vaccine or therapeutic drug is currently available for ZIKV. We have previously shown that recombinant ZIKV E80 protein induced potent neutralizing antibody response and protected mice from lethal viral challeng...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Panke, Zhang, Chao, Li, Min, Ma, Weimin, Xiong, Pei, Liu, Qingwei, Zou, Gang, Lavillette, Dimitri, Yin, Feifei, Jin, Xia, Huang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997156/ https://www.ncbi.nlm.nih.gov/pubmed/32025335 http://dx.doi.org/10.1038/s41421-019-0140-8

Ejemplares similares

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2018)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Investigation of the immunogenicity of Zika glycan loop
por: Henderson, Elizabeth A., et al.
Publicado: (2020)

The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies
por: Kikawa, Caroline, et al.
Publicado: (2023)

The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies
por: Kikawa, Caroline, et al.
Publicado: (2023)

Cell Entry of Enveloped Viruses
por: Cosset, François-Loic, et al.
Publicado: (2011)

Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
por: Dubrovskaya, Viktoriya, et al.
Publicado: (2019)

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans
por: Huettner, Isabella, et al.
Publicado: (2022)

The HIV glycan shield as a target for broadly neutralizing antibodies
por: Doores, Katie J.
Publicado: (2015)

Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
por: Barnes, Christopher O., et al.
Publicado: (2018)

Stabilization of the V2 loop improves the presentation of V2 loop–associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers
por: de Taeye, Steven W., et al.
Publicado: (2019)

Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth
por: Wagh, Kshitij, et al.
Publicado: (2018)

VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
por: Jia, Manxue, et al.
Publicado: (2020)

New Anti-Flavivirus Fusion Loop Human Antibodies with Zika Virus-Neutralizing Potential
por: França, Renato Kaylan Alves de Oliveira, et al.
Publicado: (2022)

Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
por: Schoofs, Till, et al.
Publicado: (2019)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly
por: Tong, Yimin, et al.
Publicado: (2018)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien, J, et al.
Publicado: (2012)

HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
por: Steichen, Jon M., et al.
Publicado: (2016)

Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
por: Cottrell, Christopher A., et al.
Publicado: (2021)

The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization
por: Schorcht, Anna, et al.
Publicado: (2022)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure
por: Yang, Chunpeng, et al.
Publicado: (2019)

Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
por: Zhang, Dai, et al.
Publicado: (2019)

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies
por: Pritchard, Laura K., et al.
Publicado: (2015)

Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
por: Murin, Charles D., et al.
Publicado: (2021)

Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan
por: Umotoy, Jeffrey, et al.
Publicado: (2019)

Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)

Sialoglycovirology of Lectins: Sialyl Glycan Binding of Enveloped and Non-enveloped Viruses
por: Sriwilaijaroen, Nongluk, et al.
Publicado: (2020)

The Importance of Glycans of Viral and Host Proteins in Enveloped Virus Infection
por: Li, Yuqing, et al.
Publicado: (2021)

Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
por: Wu, Yanling, et al.
Publicado: (2017)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
por: Gallichotte, Emily N., et al.
Publicado: (2019)

Plant‐produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice
por: Yang, Ming, et al.
Publicado: (2017)

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice
por: Chen, Mei-Yu, et al.
Publicado: (2020)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
por: Yang, Mingjun, et al.
Publicado: (2017)

Glycan shield of the ebolavirus envelope glycoprotein GP
por: Peng, Weiwei, et al.
Publicado: (2022)

A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization
por: Frumence, Etienne, et al.
Publicado: (2019)

A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
por: Wang, Zijun, et al.
Publicado: (2020)

Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop
por: Rockstroh, Alexandra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n38bikm3mp01l31uq9q16ev7ik